Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages 1569-1576

  Zhao, Yingjie ^a   Chen, Gong ^b   Zhao, Yao ^b   Song, Xiao ^a   Chen, Hongyan ^a   Mao, Ying ^b   Lu, Daru ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

5p15.33; fine mapping; glioma; susceptibility; TERT CLPTM1L

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CHILD; CHINESE; CHROMOSOME 5P; CHROMOSOME MAP; CLPTM1L GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLIOMA; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CHILD; CHINA; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERASE; YOUNG ADULT;

EID: 84864471078     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27417     Document Type: Article

References (28)

1. Liu YH, Shete S, Hosking FJ, Robertson LB, Bondy ML, Houlston RS,. New insights into susceptibility to glioma. Arch Neurol Chicago 2010; 67: 275-8.
2. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, et al., Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41: 899-904.
3. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, et al., Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009; 41: 905-8.
4. Chen H, Chen Y, Zhao Y, Fan W, Zhou K, Liu Y, Zhou L, Mao Y, Wei Q, Xu J, Lu D,. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol 2011; 173: 915-22.
5. Baird DM,. Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 2010; 12: e16.
6. Cheung AL, Deng W,. Telomere dysfunction, genome instability and cancer. Front Biosci 2008; 13: 2075-90.
7. Thakkar D, Shervington L, Shervington A,. Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma. Cancer Invest 2011; 29: 113-22.
8. Falchetti ML, Pallini R, D'Ambrosio E, Pierconti F, Martini M, Cimino-Reale G, Verna R, Maira G, Larocca LM,. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int J Cancer 2000; 88: 895-901.
9. Wang L, Wei QY, Wang LE, Aldape KD, Cao YM, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, et al., Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 2006; 24: 1627-32.
10. Wang K, Dickson SP, Stolle CA, Krantz ID, Goldstein DB, Hakonarson H,. Interpretation of association signals and identification of causal variants from genome-wide association studies. Am J Hum Genet 2010; 86: 730-42.
11. Botstein D, Risch N,. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33: 228-37.
12. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blondal T, Thorgeirsson TE, et al., Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009; 41: 221-7.
13. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y,. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 2011; 104: 535-42.
14. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q, Jin L, Huang F, et al., Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 2007; 28: 1906-13.
15. Liu YH, Zhou K, Zhang HS, Shugart YY, Chen L, Xu ZH, Zhong Y, Liu HL, Jin L, Wei QY, Huang FP, Lu D, et al., Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 2008; 29: 381-9.
16. O'Donnell MJ, Little DP, Braun A,. MassArray as an enabling technology for the industrial-scale analysis of DNA. Genet Eng News 1997; 17: 39.
17. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA,. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-34.
18. Carvajal-Carmona LG, Cazier JB, Jones AM, Howarth K, Broderick P, Pittman A, Dobbins S, Tenesa A, Farrington S, Prendergast J, Theodoratou E, Barnetson R, et al., Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet 2011; 20: 2879-88.
19. Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Orr N, Yu K, Hutchinson A, et al., Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet 2011; 20: 2869-78.
20. Bigner DD,. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity. Neurosurgery 1981; 9: 320-6.
21. Nothnagel M, Ellinghaus D, Schreiber S, Krawczak M, Franke A,. A comprehensive evaluation of SNP genotype imputation. Hum Genet 2009; 125: 163-71.
22. Pei YF, Li J, Zhang L, Papasian CJ, Deng HW,. Analyses and comparison of accuracy of different genotype imputation methods. PLoS One 2008; 3: e3551.
23. Beck S, Jin X, Sohn YW, Kim JK, Kim SH, Yin J, Pian X, Kim SC, Nam DH, Choi YJ, Kim H,. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression. Mol Cells 2011; 31: 9-15.
24. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, Spitz MR, Eisen T, et al., Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008; 40: 1407-9.
25. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, et al., Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008; 40: 1404-6.
26. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, et al., New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009; 41: 909-14.
27. Liu Z, Li G, Wei S, Niu J, Wang LE, Sturgis EM, Wei Q,. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2010; 31: 1977-81.
28. Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Lyer P, Schwartz AG,. Chromosome 5p region SNPs are associated with risk of NSCLC among women. J Cancer Epidemiol 2009; 2009: 242151.